{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:18:50Z","timestamp":1791944330704,"version":"4.3.4"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T00:00:00Z","timestamp":1560902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2019.00388","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T09:45:52Z","timestamp":1560937552000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":76,"title":["Polycystic Ovary Syndrome and NC-CAH: Distinct Characteristics and Common Findings. A Systematic Review"],"prefix":"10.3389","volume":"10","author":[{"given":"Georgios","family":"Papadakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni A.","family":"Kandaraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermioni","family":"Tseniklidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Papalou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanthia","family":"Diamanti-Kandarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,6,19]]},"reference":[{"key":"B1","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"Speiser","year":"1985","journal-title":"Am J Hum Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1210\/jcem.84.11.6148","article-title":"A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile","volume":"84","author":"Diamanti-Kandarakis","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"B4","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1055\/s-2003-43307","article-title":"21-hydroxylase-deficient nonclassic adrenal hyperplasia: the great pretender","volume":"21","author":"Moran","year":"2003","journal-title":"Semin Reprod Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1507\/endocrj.51.31","article-title":"The prevalence, molecular analysis and HLA typing of late-onset 21-hydroxylase deficiency in Turkish woman with hirsutism and polycystic ovary","volume":"51","author":"Yarman","year":"2004","journal-title":"Endocr J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1507\/endocrj.50.815","article-title":"The prevalence of late onset congenital adrenal hyperplasia in hirsute women from Central Anatolia","volume":"50","author":"Kamel","year":"2003","journal-title":"Endocr J"},{"key":"B7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1507\/endocrj.K07-053","article-title":"The prevalence of non-classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Greek women with hirsutism and polycystic ovary syndrome","volume":"55","author":"Trakakis","year":"2008","journal-title":"Endocr J"},{"key":"B8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1210\/er.21.3.245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1210\/jcem.78.4.8157702","article-title":"Clinical review 56: Nonclassic adrenal hyperplasia: current concepts","volume":"78","author":"Azziz","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1210\/jc.2005-1457","article-title":"Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism","volume":"91","author":"Carmina","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols. (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1210\/jcem-55-3-413","article-title":"A pilot newborn screening for congenital adrenal hyperplasia in Alaska","volume":"55","author":"Pang","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1210\/jc.84.7.2369","article-title":"Screening for mutations of 21-hydroxylase gene in hungarian patients with congenital adrenal hyperplasia","volume":"84","author":"Ferenczi","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1542\/peds.101.4.583","article-title":"Results of screening 1.9 million Texas newborns for 21-hydroxylase-deficient congenital adrenal hyperplasia","volume":"101","author":"Therrell","year":"1998","journal-title":"Pediatrics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1196\/annals.1315.009","article-title":"An update of congenital adrenal hyperplasia","volume":"1038","author":"New","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1530\/eje.1.01929","article-title":"Estimation of the false-negative rate in newborn screening for congenital adrenal hyperplasia","volume":"152","author":"Votava","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1210\/jc.2009-2724","article-title":"Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome. (AE-PCOS) Society","volume":"95","author":"Wild","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","first-page":"7502","DOI":"10.1038\/ncomms8502","article-title":"Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat Commun"},{"key":"B20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0015-0282(00)01662-9","article-title":"Prevalence of polycystic ovary syndrome. (PCOS) in first-degree relatives of patients with PCOS","volume":"75","author":"Kahsar-Miller","year":"2001","journal-title":"Fertil Steril"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1210\/jc.2002-021499","article-title":"Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome","volume":"88","author":"Yildiz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1210\/jc.2009-2703","article-title":"Family-based analysis of candidate genes for polycystic ovary syndrome","volume":"95","author":"Ewens","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","first-page":"8573","DOI":"10.1073\/pnas.96.15.8573","article-title":"Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin","volume":"96","author":"Urbanek","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"B24","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1159\/000342179","article-title":"Non-classic adrenal hyperplasia due to the deficiency of 21-hydroxylase and its relation to polycystic ovarian syndrome","volume":"40","author":"Pignatelli","year":"2013","journal-title":"Front Horm Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.molmed.2006.05.006","article-title":"Molecular mechanisms of insulin resistance in polycystic ovary syndrome","volume":"12","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Trends Mol Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/humupd\/dmi025","article-title":"Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth","volume":"11","author":"Diamanti-Kandarakis","year":"2005","journal-title":"Hum Reprod Update"},{"key":"B27","doi-asserted-by":"publisher","first-page":"17","DOI":"10.14310\/horm.2002.11165","article-title":"Polycystic ovary syndrome: the influence of environmental and genetic factors","volume":"5","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Hormones"},{"key":"B28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.2174\/1381612822666160714094404","article-title":"Do advanced glycation end products. (AGEs) contribute to the comorbidities of polycystic ovary syndrome. (PCOS)?","volume":"22","author":"Rutkowska","year":"2016","journal-title":"Curr Pharm Des"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2709","DOI":"10.2174\/1381612822666160216151852","article-title":"Oxidative stress in polycystic ovary syndrome","volume":"22","author":"Papalou","year":"2016","journal-title":"Curr Pharm Des"},{"key":"B31","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.fertnstert.2016.08.031","article-title":"Polycystic ovary syndrome and environmental toxins","volume":"106","author":"Rutkowska","year":"2016","journal-title":"Fertil Steril"},{"key":"B32","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1515\/hmbci-2014-0003","article-title":"Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysiological aspects","volume":"17","author":"Palioura","year":"2014","journal-title":"Horm Mol Biol Clin Investig"},{"key":"B33","doi-asserted-by":"publisher","first-page":"3078","DOI":"10.1210\/jcem.83.9.5090","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B34","first-page":"311","article-title":"Etiological review of hirsutism in 250 patients","volume":"25","author":"Moran","year":"1994","journal-title":"Arch Med Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0015-0282(00)00566-5","article-title":"Prevalence of 21-hydroxylase-deficient nonclassic adrenal hyperplasia and insulin resistance among hirsute women from Puerto Rico","volume":"74","author":"Romaguera","year":"2000","journal-title":"Fertil Steril"},{"key":"B36","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0015-0282(16)54239-3","article-title":"11 beta-hydroxylase deficiency in hyperandrogenism","volume":"55","author":"Azziz","year":"1991","journal-title":"Fertil Steril"},{"key":"B37","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/j.1365-2362.1992.tb01425.x","article-title":"Late-onset congenital adrenal hyperplasia in women with hirsutism","volume":"22","author":"Arnaout","year":"1992","journal-title":"Eur J Clin Invest"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000341673","article-title":"Polycystic ovary syndrome: definitions, phenotypes and diagnostic approach","volume":"40","author":"Livadas","year":"2013","journal-title":"Front Horm Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1161\/01.CIR.103.10.1410","article-title":"Polycystic ovary syndrome is associated with endothelial dysfunction","volume":"103","author":"Paradisi","year":"2001","journal-title":"Circulation"},{"key":"B40","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2217\/17455057.4.6.583","article-title":"Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome","volume":"4","author":"Christakou","year":"2008","journal-title":"Womens Health"},{"key":"B41","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/humupd\/dmg044","article-title":"Ultrasound assessment of the polycystic ovary: international consensus definitions","volume":"9","author":"Balen","year":"2003","journal-title":"Hum Reprod Update"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/0002-9378(92)91779-A","article-title":"Does ethnicity influence the prevalence of adrenal hyperandrogenism and insulin resistance in polycystic ovary syndrome?","volume":"167","author":"Carmina","year":"1992","journal-title":"Am J Obstet Gynecol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1210\/jcem-63-2-418","article-title":"Clinical and biological phenotypes in late-onset 21-hydroxylase deficiency","volume":"63","author":"Dewailly","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1365-2265.1990.tb03887.x","article-title":"The prevalence of polycystic ovaries in patients with congenital adrenal hyperplasia and their close relatives","volume":"33","author":"Hague","year":"1990","journal-title":"Clin Endocrinol."},{"key":"B45","volume-title":"Diagnostic Criteria for Polycystic Ovary Syndrome: Towards a Rational Approach","author":"Zawadzki","year":"1992"},{"key":"B46","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/bmj.293.6543.355","article-title":"Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism","volume":"293","author":"Adams","year":"1986","journal-title":"Br Med J."},{"key":"B47","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/eje.0.1490439","article-title":"Prevalence of polycystic ovaries in women with androgenic alopecia","volume":"149","author":"Cela","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2265.2000.00884.x","article-title":"The prevalence of polycystic ovaries in women with type 2 diabetes mellitus","volume":"52","author":"Conn","year":"2000","journal-title":"Clin Endocrinol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1210\/jcem.86.6.7612","article-title":"Metabolic and steroidogenic alterations related to increased frequency of polycystic ovaries in women with a history of gestational diabetes","volume":"86","author":"Koivunen","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"B50","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S0140-6736(88)91612-1","article-title":"Polycystic ovaries\u2013a common finding in normal women","volume":"1","author":"Polson","year":"1988","journal-title":"Lancet"},{"key":"B51","doi-asserted-by":"publisher","first-page":"235","DOI":"10.3109\/09513598709023610","article-title":"Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies","volume":"1","author":"Hull","year":"1987","journal-title":"Gynecol Endocrinol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1093\/oxfordjournals.humrep.a136243","article-title":"Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients","volume":"10","author":"Balen","year":"1995","journal-title":"Hum Reprod"},{"key":"B53","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.fertnstert.2009.06.025","article-title":"The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia","volume":"94","author":"Pall","year":"2010","journal-title":"Fertil Steril"},{"key":"B54","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/S0015-0282(16)44355-4","article-title":"The partial adrenocortical hydroxylase deficiency syndrome in infertile women","volume":"32","author":"Birnbaum","year":"1979","journal-title":"Fertil Steril"},{"key":"B55","doi-asserted-by":"publisher","first-page":"754","DOI":"10.23736\/S0026-4784.18.04230-2","article-title":"Pregnancy complications in infertile patients with polycystic ovary syndrome: updated evidence","volume":"70","author":"Palomba","year":"2018","journal-title":"Minerva Ginecol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1210\/jcem.83.4.4707","article-title":"High prevalence of polycystic ovaries and associated clinical, endocrine, and metabolic features in women with previous gestational diabetes mellitus","volume":"83","author":"Holte","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"B58","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1210\/jcem.74.3.1310999","article-title":"Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"74","author":"Feldman","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1210\/jc.2006-0062","article-title":"Reproductive outcome of women with 21-hydroxylase-deficient nonclassic adrenal hyperplasia","volume":"91","author":"Moran","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1210\/jc.2009-1383","article-title":"Fertility in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"95","author":"Bidet","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1210\/jc.2008-1582","article-title":"Clinical and molecular characterization of a cohort of 161 unrelated women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency and 330 family members","volume":"94","author":"Bidet","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B62","doi-asserted-by":"publisher","first-page":"E161","DOI":"10.1210\/jc.2010-0319","article-title":"Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"96","author":"Finkielstain","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","first-page":"340","DOI":"10.23736\/S0391-1977.17.02609-8","article-title":"Is cardiovascular risk in women with PCOS a real risk? Current insights","volume":"42","author":"Papadakis","year":"2017","journal-title":"Minerva Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"key":"B65","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"B66","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/humrep\/dem356","article-title":"Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome","volume":"23","author":"Cascella","year":"2008","journal-title":"Hum Reprod"},{"key":"B67","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva","year":"2012","journal-title":"Endocr Rev"},{"key":"B68","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1385\/ENDO:30:1:13","article-title":"Insulin resistance in PCOS","volume":"30","author":"Diamanti-Kandarakis","year":"2006","journal-title":"Endocrine"},{"key":"B69","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2337\/diacare.22.1.141","article-title":"Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome","volume":"22","author":"Ehrmann","year":"1999","journal-title":"Diabetes Care"},{"key":"B70","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1067\/mob.2000.108020","article-title":"21-Hydroxylase-deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study","volume":"183","author":"Moran","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1210\/jcem.87.4.8398","article-title":"Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia\/insulin resistance","volume":"87","author":"Arslanian","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B73","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1677\/joe.0.1810355","article-title":"Modulation of steroidogenic enzymes by orphan nuclear transcriptional regulation may control diverse production of cortisol and androgens in the human adrenal","volume":"181","author":"Kelly","year":"2004","journal-title":"J Endocrinol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1210\/jcem.84.1.5393","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1210\/jcem.87.3.8305","article-title":"Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome","volume":"87","author":"Palmert","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B76","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.metabol.2015.08.010","article-title":"Advanced glycation end products: a link between metabolic and endothelial dysfunction in polycystic ovary syndrome?","volume":"64","author":"Pertynska-Marczewska","year":"2015","journal-title":"Metabolism"},{"key":"B78","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s13679-014-0127-6","article-title":"Aspects of cardiometabolic risk in women with polycystic ovary syndrome","volume":"3","author":"Paterakis","year":"2014","journal-title":"Curr Obes Rep"},{"key":"B79","doi-asserted-by":"publisher","first-page":"3675","DOI":"10.1210\/jc.2011-2935","article-title":"Uncertainty remains in women with PCOS regarding the increased incidence of cardiovascular disease later in life, despite the indisputable presence of multiple cardiovascular risk factors at a young age","volume":"96","author":"Fauser","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.fertnstert.2009.09.025","article-title":"Prevalence and risk of depressive disorders in women with polycystic ovary syndrome. (PCOS)","volume":"94","author":"Bhattacharya","year":"2010","journal-title":"Fertil Steril"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/humrep\/dex044","article-title":"High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"32","author":"Cooney","year":"2017","journal-title":"Hum Reprod"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.fertnstert.2006.11.039","article-title":"Increased risk of depressive disorders in women with polycystic ovary syndrome","volume":"87","author":"Hollinrake","year":"2007","journal-title":"Fertil Steril"},{"key":"B83","doi-asserted-by":"publisher","first-page":"405","DOI":"10.5603\/GP.2016.0016","article-title":"Determinants of emotional problems and mood disorders in women with polycystic ovary syndrome","volume":"87","author":"Glowinska","year":"2016","journal-title":"Ginekol Pol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jsxm.2015.11.002","article-title":"Sexual function and depressive symptoms in young women with nonclassic congenital adrenal hyperplasia","volume":"13","author":"Krysiak","year":"2016","journal-title":"J Sex Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1111\/j.1365-2133.2005.06426.x","article-title":"A randomized controlled trial of laser treatment among hirsute women with polycystic ovary syndrome","volume":"152","author":"Clayton","year":"2005","journal-title":"Br J Dermatol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamadermatol.2016.0358","article-title":"Clinician vs Self-ratings of hirsutism in patients with polycystic ovarian syndrome: associations with quality of life and depression","volume":"152","author":"Pasch","year":"2016","journal-title":"JAMA Dermatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1056\/NEJM198507253130404","article-title":"Late-onset adrenal hyperplasia in hirsutism","volume":"313","author":"Kuttenn","year":"1985","journal-title":"N Engl J Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.fertnstert.2006.03.004","article-title":"Nonclassic adrenal hyperplasia","volume":"86","author":"Moran","year":"2006","journal-title":"Fertil Steril"},{"key":"B89","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1529-8019.2006.00077.x","article-title":"Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome","volume":"19","author":"Lowenstein","year":"2006","journal-title":"Dermatol Ther"},{"key":"B90","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"(PCOS)","volume":"19","author":"Revised","year":"2004","journal-title":"Hum Reprod"},{"key":"B91","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"B92","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/j.fertnstert.2006.03.005","article-title":"Nonclassic 21-hydroxylase deficiency","volume":"86","author":"New","year":"2006","journal-title":"Fertil Steril"},{"key":"B93","doi-asserted-by":"publisher","first-page":"96351","DOI":"10.18632\/oncotarget.19180","article-title":"The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis","volume":"8","author":"Ding","year":"2017","journal-title":"Oncotarget"},{"key":"B94","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B95","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1530\/EJE-11-0019","article-title":"Phenotypic profiling of parents with cryptic nonclassic congenital adrenal hyperplasia: findings in 145 unrelated families","volume":"164","author":"Nandagopal","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1210\/jcem-70-3-642","article-title":"Cyproterone acetate versus hydrocortisone treatment in late-onset adrenal hyperplasia","volume":"70","author":"Spritzer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"B97","first-page":"195","article-title":"Novel strategies in the management of polycystic ovary syndrome","volume":"40","author":"Spritzer","year":"2015","journal-title":"Minerva Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00388\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T09:45:56Z","timestamp":1560937556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fendo.2019.00388\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,19]]},"references-count":97,"alternative-id":["10.3389\/fendo.2019.00388"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2019.00388","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,19]]},"article-number":"388"}}